NR 662 Week 8 Closing Synthesis Example

Closing Synthesis: The Heart Failure Transitions Nurse as a Checkable Position, the Program Material That Supports It, the Strongest Objection and What I Will Hold Myself To

Student Name

College of Nursing, Chamberlain University

NR 662: Advanced Nursing Role Synthesis

Instructor Name

Month Day, Year

Closing Synthesis: The Heart Failure Transitions Nurse as a Checkable Position, the Program Material That Supports It, the Strongest Objection and What I Will Hold Myself To

The Position, Stated So It Can Be Checked

The heart failure transitions nurse takes, from the RN case manager, the booking of the first cardiology visit for heart failure patients; shares, with the clinical pharmacist, the comparison of discharge and inpatient medication lists, with the pharmacist keeping every dosing recommendation; and takes on three pieces of work nobody holds now: teaching daily weights and thresholds before the discharge day, a phone check in the first three days at home and same-day escalation to the clinic. It does this to a standard of a booked visit within seven days for most patients and a call within 72 hours for nearly all. It sends dose changes, insurance authorization, placement, palliative discussions and discharge decisions elsewhere.

Why One Position and Not Better Coordination

The boundary analysis showed that three activities have no owner at all. Better coordination between existing jobs cannot give an owner to work nobody holds. The leadership material from the program applies here: accountability that is shared among four positions belongs, in practice, to none of them on a Friday afternoon.

Program Material as Reasoning

Cost was raised by the director in the first conversation, so the finance material entered there: the trial is bounded to six months, about $68,000 by estimate, with no offset claimed until the finance office provides one. A readmission figure was claimed, so the research material entered there: the studies behind the role are from other systems and used advanced practice nurses with home visits (Naylor et al., 2004), so the claim for this unit is smaller. Statistical reasoning entered when the measures were chosen: with about 260 discharges in six months, readmission cannot be the primary measure, so the seven-day visit rate, which the role directly controls, is. Policy entered through the federal readmissions program and through the guideline's placement of dose titration with prescribers (Heidenreich et al., 2022).

The Strongest Objection

"This is a case manager with a different title." The answer comes from the table in week 3. The case manager keeps home health, authorization and placement, and gives up only the cardiology booking for heart failure patients. The new role's core is teaching weights, the call and escalation, none of which the case manager does or has time to do. If the objection were right, the case managers would already be making the calls. They are not, because their work is built around getting patients out, not around what happens after.

A second objection, that a pharmacist could do it, is answered in the justification memo: a pharmacist would close the weekday medication gap while leaving the phone check, the weight teaching and the visit booking where they are now, with nobody.

Evidence, Tightened

From week 4: a one-page teaching sheet drafted with a pharmacist was used for 14 discharges; 12 patients could state their threshold, and two of eleven reached by phone called the clinic about weight gain and were seen within two days. That is a small occasion, and it supports only the claim that the role's core work can be done by a nurse working with a pharmacist. From week 5: the 27% readmission rate for Friday and weekend discharges, against 19% for other days, a pattern a weekday role with Monday calls addresses only partly. From week 7: three June readmissions, each tied to one of the joins the role would hold.

What Others Contributed to the Argument

The boundary table was corrected by the pharmacist and agreed by the case manager. The memo was read by three managers before it went to the director. The teaching sheet was shaped by a pharmacist and an educator. The position as stated is therefore not mine alone; it is what the neighboring positions have agreed they can live with, which is a stronger claim than any I could make by myself. A position agreed at its edges by the people next door is more likely to survive its first difficult month than one argued for by its future holder alone.

What the Role Cannot Do

Cover weekends. Change doses. Visit homes. Guarantee fewer readmissions. Each limit was stated in earlier weeks and is repeated here because a synthesis that drops its limits overstates its case. A director reading only this paper should still know exactly what the trial will not buy. Care transitions coaching, built around one named contact for the patient, cut readmissions (Coleman et al., 2006), but this role is narrower than that model and will be judged on its own measures.

Where the Program's Material Did Not Help

Nothing in the program prepared me for the conversation with the case managers about giving up the booking. Their concern was not workload but control: the booking was one of the few parts of the transition they could see through to the end. The answer came from listening, not from a framework, and it changed the proposal: the case manager keeps the booking for every other diagnosis and is copied on every heart failure booking.

What I Will Hold Myself To in the First Year

If the trial is approved and I hold the role: a seven-day visit rate of at least 60% by the end of month six, reported monthly; a 72-hour call completion rate of at least 85%; the 40 clinic hours with the nurse practitioner completed by March 2027; the certification examination passed by June 2027; and a written report to the director at month six that states the readmission figure with its uncertainty, whatever it is. Anyone can ask me about each of these in a year and get a yes or a no, and the month-six report will answer the first two in writing.

What the Program Changed

I began the program thinking a new role was justified by a gap in care. I end it thinking a new role is justified by a gap in ownership, stated as events, priced, bounded and measured. The difference is what a director can say yes to, and it is the main thing I will take from the program into the role, whether or not the trial is approved.

References

Coleman, E. A., Parry, C., Chalmers, S., & Min, S.-J. (2006). The care transitions intervention: Results of a randomized controlled trial. Archives of Internal Medicine, 166(17), 1822-1828. https://doi.org/10.1001/archinte.166.17.1822

Heidenreich, P. A., Bozkurt, B., Aguilar, D., Allen, L. A., Byun, J. J., Colvin, M. M., Deswal, A., Drazner, M. H., Dunlay, S. M., Evers, L. R., Fang, J. C., Fedson, S. E., Fonarow, G. C., Hayek, S. S., Hernandez, A. F., Khazanie, P., Kittleson, M. M., Lee, C. S., Link, M. S., . . . Yancy, C. W. (2022). 2022 AHA/ACC/HFSA guideline for the management of heart failure: A report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation, 145(18), e895-e1032. https://doi.org/10.1161/CIR.0000000000001063

Naylor, M. D., Brooten, D. A., Campbell, R. L., Maislin, G., McCauley, K. M., & Schwartz, J. S. (2004). Transitional care of older adults hospitalized with heart failure: A randomized, controlled trial. Journal of the American Geriatrics Society, 52(5), 675-684. https://doi.org/10.1111/j.1532-5415.2004.52202.x